AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A better understanding of the human immune response to potential agents of bioterror and rapid development of countermeasures such as vaccines and therapies are among the objectives of a new program announced by the National Institute of Allergy and Infectious Diseases (NIAID), one of the U.S. National Institutes of Health (NIH).
"NIH is dedicated to supporting research that will help in fighting the war on terror," said NIH Director Elias A. Zerhouni, MD.
NIAID has named five Cooperative Centers for Translational Research on Human Immunology and Biodefense. Approximately $85 million over 4 1/2 years will support research at:
1) Baylor Research Institute (Dallas)
2) Dana-Farber Cancer Institute (Boston)
3) Emory University School of Medicine (Atlanta)
4) Stanford University School of Medicine (Stanford)